,
your personalized virtual assistant to find clinical trials. Go head, 
Esther H. Rehmus, MD
McDowell Cancer Center at Akron ...Akron, Ohio - 44307 (330-344-6448) |
- CLINICAL TRIALS 31
- CONDITIONS49
- INTERVENTIONS65
- SINCE1991
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012
Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB Stage IIIC or Stage IV Breast Cancer
July 2008 - August 2009
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
March 2008 - May 2012
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma or Plasmacytoma
June 2002 -
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia
August 2006 - February 2008
Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance
November 2003 -
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012
Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
December 2008 - January 2011
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
March 2007 - November 2011
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012
Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
December 2008 - November 2010
Iodine I 131 Tositumomab Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma
September 2008 - October 2012
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
May 2005 - March 2010
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011
Idarubicin Cytarabine and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
August 2009 - June 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Amyloidosis
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Fatigue
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Bone Neoplasms
Bone Marrow Diseases
Carcinoma, Small Cell
Neurotoxicity Syndromes
Precancerous Conditions
Myeloproliferative Disorders
Colorectal Neoplasms
Carcinoma, Transitional Cell
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Hematologic Neoplasms
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Lymphoma, Follicular
Waldenstrom Macroglobulinemia
Ureteral Neoplasms
Osteonecrosis
Urologic Neoplasms
Monoclonal Gammopathies, Benign
Plasmacytoma
Paraproteinemias
Urethral Neoplasms
Placebo
Intensity-Modulated Radiation Therapy
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Rituximab
Filgrastim
Celecoxib
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Aflibercept
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Dasatinib
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Prednisone
Pemetrexed Disodium
Capecitabine
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Cytarabine
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Temsirolimus
Polymerase Chain Reaction
Sunitinib Malate
Microarray Analysis
Trastuzumab
Lapatinib Ditosylate
Cixutumumab
Sorafenib Tosylate
Fluorescence In Situ Hybridization
Azacitidine
Mutation Analysis
Cetuximab
Iodine I 131 Tositumomab
Biologic Sample Preservation Procedure
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Irinotecan Hydrochloride
Ixabepilone
Gemtuzumab Ozogamicin
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Topotecan Hydrochloride
Pravastatin
Ac Regimen
Cytogenetic Analysis
Duloxetine Hydrochloride
Idarubicin
Vinorelbine Ditartrate
Entinostat
Placebo Administration
Tositumomab
Acetyl-L-Carnitine Hydrochloride
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
